Established in 2021, Beijing HumaDX Tech Co., Ltd. has built a full-automatic multiplex platform with multiplex flow fluorescence technology as its core. It is dedicated to providing clinical customers with high-throughput, high-sensitivity, and multiparameter parallel platforms and corresponding reagents. HumaDX is a technology-driven enterprise that could provide multiplex microspheres, fully automatic multiplex immunoassay instrument and corresponding reagents.
Except for the multiplex platform, HumaDX also has the full-automatic chemiluminescence platform and the full-automatic immunoblotting platform. As a technology-driven company, more than 30 patents have been applied, and there are more than 170 products have been issued CE certificates.
Three technology platforms, providing comprehensive diagnostic solutions